跳至主要内容
临床试验/NCT05124015
NCT05124015已完成不适用

Exercise Capacity Respiratory Muscle Strength Pulmonary Function Dyspnea and Physical Activity in Pediatric Pulmonary Arterial Hypertension

Gazi University1 个研究点 分布在 1 个国家目标入组 33 人开始时间: 2019年11月10日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
33
试验地点
1
主要终点
Exercise capacity

研究概览

简要总结

The primary aim of this study was to evaluate exercise capacity, respiratory muscle strength, pulmonary function, dyspnea and physical activity levels in pediatric PAH patients and compare them with healthy controls.

The secondary aim of the study was; To investigate the relationship of dyspnea with exercise capacity, respiratory muscle strength, respiratory functions, physical activity and blood count parameters in pediatric PAH patients.

详细描述

Pulmonary arterial hypertension (PAH) is a mean pulmonary artery pressure of 25 mmHg or more at rest. Since the diagnosis of PAH can be made mostly in the late phase of the disease, severe functional and hemodynamic problems are prevalent in patients. In addition, patients commonly present with dyspnea, fatigue, weakness, general exercise intolerance, chest pain, syncope, and abdominal distension. These signs and symptoms are due to reduced oxygen consumption and decreased cardiac output. Activity dyspnea is evident in patients in the early stages of the disease. There is limited number of studies in pediatric PAH patients investigating exercise intolerance. While the cardiopulmonary exercise test can be safely performed in pediatric PAH patients, the six-minute walk test is both an independent predictor of prognosis and reflects the severity of the disease in these patients. However, there are no studies in the literature investigating and comparing exercise capacity, respiratory muscle strength, respiratory functions, dyspnea, and physical activity levels in pediatric PAH patients compared to age- and sex-matched healthy children. For this reason, in this study, the level of physical impairments of children with pediatric PAH was investigated for the first time compared to healthy children. In addition, there has been no study in the literature investigated the relationship between dyspnea, which can be seen significantly from the early stages of the disease in pediatric PAH patients, with exercise capacity, respiratory function, respiratory muscle strength, physical activity levels and blood count parameters.

It is a cross-sectional study. At least 15 PAH patients and 15 age-and sex-matched healthy controls were aimed to include in the study. Individuals' exercise capacity using six minute walk test, respiratory muscle strength using a mouth pressure device, pulmonary function using spirometry, dyspnea using Modified Borg scale, physical activity using multi-sensory activity monitor were evaluated. The assessments were completed in two days.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
6 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • The inclusion criteria for patients with PAH are as follows:
  • Between the ages of 6-18
  • Diagnosed with pulmonary arterial hypertension
  • Clinically stable and receiving standard medical treatment
  • The inclusion criteria for healthy children are as follows:
  • To be between the ages of 6-18

排除标准

  • The exclusion criteria for patients with PAH are as follows:
  • Having any acute infection, orthopedic, neurological, cooperation, vision or hearing problems that may interfere during the measurements
  • The exclusion criteria for healthy children are as follows:
  • Having any acute or chronic illness
  • Active or ex-smoker

结局指标

主要结局

Exercise capacity

时间窗: First Day

Functional exercise capacity was evaluated using the 6- Minute Walk Test. 6- Minute Walk Test will be applied according to the American Thoracic Society (ATS) and European Respiratory Society (ERS) criteria.

次要结局

  • Pulmonary function (FEV1 / FVC)(First day)
  • Pulmonary function (Peak flow rate (PEF))(First Day)
  • Dyspnea(First day)
  • Physical activity (Time spent lying down (min / day) days))(Second day)
  • Pulmonary function (Forced expiratory volume in the first second (FEV1))(First day)
  • Physical activity (Average metabolic equivalent (MET / day))(Second day)
  • Respiratory muscle strength(First Day)
  • Pulmonary function (Forced vital capacity (FVC))(First Day)
  • Pulmonary function (Flow rate 25-75% of forced expiratory volume (FEF 25-75%))(First Day)
  • Physical activity (Physical activity time (min / day))(Second day)
  • Physical activity (Number of steps (steps / day))(Second day)
  • Physical activity (Total energy expenditure)(Second Day)
  • Physical activity (Active energy expenditure (joule / day))(Second Day)
  • Physical activity (Sleep time (min / day))(Second day)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Meral Boşnak Güçlü

Prof. Dr.

Gazi University

研究点 (1)

Loading locations...

相似试验